{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:33:28Z","timestamp":1791210808751,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000029.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000}}],"reference-count":105,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000029.pub3","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:04:51Z","timestamp":1395792291000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Oral antiplatelet therapy for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"Peter AG","family":"Sandercock","sequence":"first","affiliation":[{"name":"University of Edinburgh; Centre for Clinical Brain Sciences (CCBS); The Chancellor's Building 49 Little France Crescent Edinburgh UK EH16 4SB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Counsell","sequence":"additional","affiliation":[{"name":"University of Aberdeen; Division of Applied Health Sciences; Polwarth Building Foresterhill Aberdeen UK AB25 2ZD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chiun","family":"Tseng","sequence":"additional","affiliation":[{"name":"National Sun Yat-Sen University; Department of Business Management; 70 Lien-Hai Road Kaohsiung, Taiwan China 804"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Cecconi","sequence":"additional","affiliation":[{"name":"University of Edinburgh; Division of Clinical Neurosciences; Western General Hospital Crewe Road Edinburgh UK EH4 2XU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"10.1002\/14651858.CD000029.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"A randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","author":"CAST (Chinese Acute Stroke Trial) Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/000331979004100701","article-title":"Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study","volume":"41","author":"Ciuffetti","year":"1990","journal-title":"Angiology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","author":"Multicentre Acute Stroke Trial-Italy (MAST-I) Group","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0005|cit5","volume-title":"Thromboses veineuses des membres inferieures et embolies pulmonaires au cours des accidents vasculaires cerebraux. A propos d'un essai comparatif de traitment preventif. (These pour le doctorat d'etat en medicine)","author":"Pince","year":"1981"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2796.2003.01233.x","article-title":"Aspirin in the prevention of progressing stroke: a randomized controlled study","volume":"254","author":"R\u00f6d\u00e9n-J\u00fcllig","year":"2003","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0007|cit7","unstructured":"Turpie AGG Dobkin B McKenna R A trial of ticlopidine, an antiplatelet agent, for acute cerebral infarction Guildford: Sanofi Winthrop (Sanofi internal report 1983.001.6.188) 1983"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0008|cit8","unstructured":"Utsumi H Evaluation of utility of ticlopidine, an antiplatelet agent, for acute cerebral infarction Guildford: Sanofi Winthrop (Sanofi internal report 001.6.128) 1984"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.STR.31.3.601","article-title":"Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose escalation study","volume":"31","author":"The Abciximab in Ischemic Stroke Investigators","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.STR.0000157668.39374.56","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke. Results of a randomized phase 2 trial","volume":"36","author":"Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0014|cit14","unstructured":"Aoki T Prolonged administration of ticlopidine to cerebral infarction Unpublished"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.CIR.102.7.728","article-title":"Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb\/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease","volume":"102","author":"Harrington","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030006058901700104","article-title":"Ticlopidine-pentoxiphylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents","volume":"17","author":"Apollonia","year":"1989","journal-title":"Journal of International Medical Research"},{"issue":"9843","key":"10.1002\/14651858.CD000029.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0018|cit18","first-page":"585","article-title":"Clinical and laboratory results obtained with defibrotide in the case of acute stroke","volume":"62","author":"Balkuv-Ulutin","year":"1989","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1067\/mhj.2000.105107","article-title":"Design of the blockade of the glycoprotein IIb\/IIIa receptor to avoid vascular occlusion (BRAVO) trial","volume":"139","author":"Topol","year":"2000","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0020|cit20","first-page":"167","article-title":"Hemorrheological study on the effect of acupuncture in treating cerebral infarction","volume":"8","author":"Chen","year":"1988","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.STR.31.10.2517-a","article-title":"Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab","volume":"31","author":"Cheung","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0022|cit22","unstructured":"Pancioli A for the CLEAR Trial Investigators The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (the CLEAR stroke trial): blinded results from tier I and II Proceedings of the International Stroke Conference; 2006 February 16-18; Kissimmee (FL), USA 2006 (Abstract CTP17)"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0023|cit23","unstructured":"Pancioli AM Broderick JP the CLEAR Stroke Trial Investigators The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (The CLEAR Stroke Trial) Proceedings of the 29th International Stroke Conference; 2004 February 5-7; San Diego (CA), USA 2004 (Abstract CTP16)"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0024|cit24","first-page":"s23","article-title":"Study of effect of picotamide, ASA, and picotamide plus ASA on platelet aggregation in ischemic stroke","volume":"20 Suppl 4","author":"D'Andrea","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0025|cit25","first-page":"91","article-title":"Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction","volume":"10","author":"D'Andrea","year":"1995","journal-title":"Functional Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0026|cit26","first-page":"250","article-title":"Clinical research of ligustrazine for acute cerebral infarction","volume":"13","author":"Fan","year":"2003","journal-title":"Chinese Journal of Hemorheology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0028|cit28","first-page":"148","article-title":"The effect of ligustrazine, aspirin and betahistine on the platelet aggregation of ischemic stroke patients","volume":"22","author":"Gao","year":"1989","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0029|cit29","first-page":"S162","article-title":"Levamisol, a new treatment for cerebral infarction [Abstract]","volume":"241 Suppl 1","author":"Garcia Tigera","year":"1994","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0030|cit30","first-page":"409","article-title":"Preliminary report on the effectiveness of prostacyclin in stroke","volume":"11","author":"Hakim","year":"1984","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0031|cit31","unstructured":"Iida N Clinical experience with ticlopidine in patients with cerebral infarction Unpublished data 1984"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1159\/000327035","article-title":"The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial","volume":"31","author":"Uchiyama","year":"2011","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.STR.20.5.609","article-title":"Effect of therapy on platelet activation factor induced aggregation in acute stroke","volume":"20","author":"Joseph","year":"1989","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.58.3.474","article-title":"Ischaemic brain tissue salvaged by infarction by the GP IIb\/IIa platelet antagonist tirofiban","volume":"58","author":"Junghans","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0035|cit35","first-page":"1093","article-title":"YM-337 Yamanouchi","volume":"2","author":"Kamath","year":"2001","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0036|cit36","unstructured":"Kaye J A trial to evaluate the relative roles of dipyridamole and aspirin in the prevention of deep vein thrombosis in stroke patients Brackness (UK): Boehringer Ingelheim (Internal report trial no. CT 330\/189) 1989"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0037|cit37","first-page":"189","article-title":"Randomised trial of a new platelet anti-aggregant agent: ticlopidine","volume":"32","author":"Lecrubier","year":"1977","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0038|cit38","first-page":"302","article-title":"Study of optimal aspirin loading and maintaining dosage for cerebral infarction at acute stage","volume":"32","author":"Li","year":"1999","journal-title":"Chinese Journal of Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0039|cit39","first-page":"4","article-title":"Effect of ozagrel sodium in ameliorating the motor function of patients with acute lacunar infarct of dyskinesias: A randomized, double-blind, placebo-controlled trial","volume":"9","author":"Li","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0040|cit40","first-page":"72","article-title":"Therapeutic observation and biochemical study of calcium antagonist and anti-thromboxane A2 activity in acute ischaemic stroke","volume":"11","author":"Liu","year":"1994","journal-title":"Journal of Apoplexy and Nervous Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0041|cit41","unstructured":"Matsumoto Y Comparison of the effects between ozagrel Na combined with cilostazol and ozagrel Na alone for acute phase ischemic stroke in the territory of perforating arteries of the MCA: a randomized open trial. UMIN Clinical Trials Registry center.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0042|cit42","first-page":"548","article-title":"Aspirin and the kidney in patients with cerebral ischemia","volume":"58","author":"Monreal","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0043|cit43","first-page":"353","article-title":"Clinical usefulness of OKY-046 on the acute stage of cerebral thrombosis - double blind trial in comparison with placebo","volume":"7","author":"Ohtomo","year":"1991","journal-title":"Rinsho Iyaku (Journal of Clinical Therapeutics and Medicine)"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","article-title":"Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial","volume":"42","author":"Siebler","year":"2011","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1212\/01.WNL.0000129480.17345.4A","article-title":"The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions","volume":"62","author":"Seitz","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.0000070544.15890.0E","article-title":"Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb\/IIIa receptor antagonist","volume":"107","author":"Siebler","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0047|cit47","unstructured":"Marini C Rothwell P Di Orio F Maragliano E Efficacy and safety of ticlopidine and aspirin versus aspirin alone in the prevention of vascular events after cerebral ischaemia Unpublished 2000"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0048|cit48","unstructured":"Bath P Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke (TARDIS) http:\/\/www.controlled-trials.com\/ISRCTN47823388 http:\/\/www.tardistrial.org\/"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0049|cit49","first-page":"S415","article-title":"A randomized controlled trial of ligustrazine for acute ischemic stroke","volume":"238 Suppl 1","author":"Bo","year":"2005","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0050|cit50","first-page":"657","article-title":"Clinical investigation of ticlopidine hydrochloride in the treatment of cerebral infarction","volume":"18","author":"Yan","year":"1998","journal-title":"Chinese Journal of Practical Internal Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0051|cit51","first-page":"634","article-title":"Clinical study of low-molecular-weight heparin calcium and aspirin therapy on acute cerebral infarction","volume":"40","author":"Zhang","year":"2005","journal-title":"Chinese Pharmaceutical Journal"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0052|cit52","first-page":"87","article-title":"Effect of combined antithrombotic treatment with cilostazol for progressive stroke","volume":"5 Suppl 2","author":"Fujimoto","year":"2010","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0053|cit53","first-page":"19","article-title":"Randomized placebo-controlled trial of early aspirin used in 180 patients with acute ischaemic stroke in the elderly people","volume":"8","author":"Wang","year":"2000","journal-title":"Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0054|cit54","unstructured":"Suzuki N Cilostazol in Acute Ischemic Stroke Trial UMIN Clinical Trials Registry (UMIN-CTR). (http:\/\/www.umin.ac.jp\/ctr\/) 2006"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0055|cit55","unstructured":"Tominaga T A randomized clinical trial of an antiplatelet agent in the treatment of acute stroke: cilostazol in the prevention of acute progressing stroke (CAPS) study UMIN Clinical Trials Registry (UMIN-CTR) (http:\/\/www.umin.ac.jp\/ctr\/) 2009"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics - 2013 update: a report from the American Heart Association","volume":"127:","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.STR.20.6.828","article-title":"Inter-observer agreement for the assessment of handicap in stroke patients","volume":"20","author":"Bamford","year":"1989","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000029.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000177.pub2","article-title":"Prostacyclin and analogues for acute ischaemic stroke","author":"Bath","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000029.pub3-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000162.pub2","article-title":"Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke","author":"Bath","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000327036","article-title":"Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial","volume":"32","author":"Lee","year":"2011","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000108505","article-title":"Telephone interview for stroke outcome assessment","volume":"4","author":"Candelise","year":"1994","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0067|cit67","first-page":"S148-S154","article-title":"Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study","volume":"88","author":"Chairangsarit","year":"2005","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST Collaborative Groups","volume":"31","author":"Chen","year":"2000","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000029.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005208.pub2","article-title":"Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke","author":"Ciccone","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.313.7058.652","article-title":"Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic review of randomised trials","volume":"313","author":"Collins","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0072|cit72","unstructured":"Canadian Stroke Network and Heart and Stroke Foundation of Canada Canadian Best Practice Recommendations for Stroke Care: Update 2010 http:\/\/www.canadianstrokenetwork.ca\/ December 2010"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2005.11.013","article-title":"Aspirin to prevent heart attack and stroke: what's the right dose?","volume":"119","author":"Dalen","year":"2006","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.27.3.415","article-title":"Complications after acute stroke","volume":"27","author":"Davenport","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000108159","article-title":"Are simple questions a valid measure of outcome after stroke?","volume":"7","author":"Dennis","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1474-4422(09)70361-8","article-title":"Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Dengler","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"457-507","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25:","author":"The European Stroke Organisation Executive Committee and the ESO Writing Committee","year":"2008","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/STROKEAHA.110.586727","article-title":"Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial","volume":"41","author":"Hankey","year":"2010","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0079|cit79","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.60.4.371","article-title":"Study design of the International Stroke Trial (IST), baseline data and outcome in 984 randomised patients in the pilot study","volume":"60","author":"International Stroke Trial Pilot Study Collaborative Group","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000029.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009716","article-title":"Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack","author":"Kamal","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3-4","key":"10.1002\/14651858.CD000029.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000065661","article-title":"Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies","volume":"14","author":"Keir","year":"2002","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0084|cit84","volume-title":"Stroke: A focus of opportunity","author":"Dick","year":"1995"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","article-title":"Mortality by cause for eight regions of the world: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischaemic stroke","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000029.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000012.pub3","article-title":"Randomisation to protect against selection bias in healthcare trials","author":"Odgaard-Jensen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"470S","DOI":"10.1378\/chest.114.5_Supplement.470S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects","volume":"114","author":"Patrono","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0091|cit91","unstructured":"POINT Investigators Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial http:\/\/www.pointtrial.org"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0092|cit92","unstructured":"Royal College of Physicians National Clinical Guidelines for Stroke, Fourth edition 2012 http:\/\/www.rcplondon.ac.uk\/resources\/stroke-guidelines September 2012"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0093|cit93","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"9","key":"10.1002\/14651858.CD000029.pub3-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000419.pub3","article-title":"Piracetam for acute ischaemic stroke","author":"Ricci","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","article-title":"Preventing stroke: saving lives around the world","volume":"6","author":"Strong","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0096|cit96","first-page":"I39-44","article-title":"Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience","volume":"14","author":"Suri","year":"2008","journal-title":"Medical Science Monitor"},{"issue":"9","key":"10.1002\/14651858.CD000029.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000197.pub3","article-title":"Organised inpatient (stroke unit) care for stroke","author":"Stroke Unit Trialists' Collaboration","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000029.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1212\/WNL.0b013e31829bfde3","article-title":"Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review","volume":"81","author":"Tsai","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0733-8619(18)30241-X","article-title":"Aspirin: dose and indications in modern stroke prevention","volume":"10","author":"Gijn","year":"1992","journal-title":"Neurologic Clinics"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/01.STR.25.2.278","article-title":"Evidence for episodic platelet activation in acute ischaemic stroke","volume":"25","author":"Kooten","year":"1994","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.STR.28.8.1557","article-title":"Platelet activation and lipid peroxidation in patients with acute ischaemic stroke","volume":"28","author":"Kooten","year":"1997","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD000029.pub3-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213.pub2","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0103|cit103","first-page":"775","article-title":"Stroke, transient ischaemic attacks, and intracranial venous thrombosis","volume-title":"Brain's Diseases of the Nervous System","author":"Warlow","year":"2001"},{"key":"10.1002\/14651858.CD000029.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1179\/1743132812Y.0000000022","article-title":"Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials","volume":"34","author":"Zhang","year":"2012","journal-title":"Neurological Research"},{"issue":"2","key":"10.1002\/14651858.CD000029.pub3-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000029","article-title":"Antiplatelet therapy for acute ischaemic stroke","author":"Sandercock","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000029.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000029.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:53:24Z","timestamp":1628542404000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000029.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":105,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000029.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000029.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}